Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase.

Abstract

The NAD(+)-dependent deacetylase SIRT1 is a key regulator of several aspects of metabolism and aging. SIRT1 activation is beneficial for several human diseases, including metabolic syndrome, diabetes, obesity, liver steatosis, and Alzheimer disease. We have recently shown that the protein deleted in breast cancer 1 (DBC1) is a key regulator of SIRT1 activity in vivo. Furthermore, SIRT1 and DBC1 form a dynamic complex that is regulated by the energetic state of the organism. Understanding how the interaction between SIRT1 and DBC1 is regulated is therefore essential to design strategies aimed to activate SIRT1. Here, we investigated which pathways can lead to the dissociation of SIRT1 and DBC1 and consequently to SIRT1 activation. We observed that PKA activation leads to a fast and transient activation of SIRT1 that is DBC1-dependent. In fact, an increase in cAMP/PKA activity resulted in the dissociation of SIRT1 and DBC1 in an AMP-activated protein kinase (AMPK)-dependent manner. Pharmacological AMPK activation led to SIRT1 activation by a DBC1-dependent mechanism. Indeed, we found that AMPK activators promote SIRT1-DBC1 dissociation in cells, resulting in an increase in SIRT1 activity. In addition, we observed that the SIRT1 activation promoted by PKA and AMPK occurs without changes in the intracellular levels of NAD(+). We propose that PKA and AMPK can acutely activate SIRT1 by inducing dissociation of SIRT1 from its endogenous inhibitor DBC1. Our experiments provide new insight on the in vivo mechanism of SIRT1 regulation and a new avenue for the development of pharmacological SIRT1 activators targeted at the dissociation of the SIRT1-DBC1 complex.

• Authors: Veronica Nin, Carlos Escande, Claudia C Chini, Shailendra Giri, Juliana Camacho-Pereira, Jonathan Matalonga, Zhenkun Lou, Eduardo N Chini
• Journal: The Journal of biological chemistry (J Biol Chem) Vol. 287 Issue 28 Pg. 23489-501 (Jul 06 2012) ISSN: 1083-351X [Electronic] United States
• PMID: 22553202 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide
• Acrylamides
• Adaptor Proteins, Signal Transducing
• CCAR2 protein, human
• Carbazoles
• N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide
• Piperidines
• Stilbenes
• NAD
• Niacinamide
• Cyclic AMP-Dependent Protein Kinases
• AMP-Activated Protein Kinases
• SIRT1 protein, human
• Sirtuin 1
• Resveratrol

Topics

• AMP-Activated Protein Kinases (metabolism)
• Acrylamides (pharmacology)
• Adaptor Proteins, Signal Transducing (genetics, metabolism, physiology)
• Amino Acid Sequence
• Animals
• Blotting, Western
• Carbazoles (pharmacology)
• Cell Line, Tumor
• Cells, Cultured
• Cyclic AMP-Dependent Protein Kinases (metabolism)
• Enzyme Activation (drug effects)
• HEK293 Cells
• Hep G2 Cells
• Humans
• Mice
• Mice, Knockout
• Models, Biological
• Mutation
• NAD (metabolism)
• Niacinamide (pharmacology)
• Phosphorylation (drug effects)
• Piperidines (pharmacology)
• RNA Interference
• Resveratrol
• Signal Transduction (drug effects, physiology)
• Sirtuin 1 (antagonists & inhibitors, genetics, metabolism)
• Stilbenes (pharmacology)